Literature DB >> 2319

Immunological similarity between NADH-cytochrome b5 reductase of erythrocytes and liver microsomes.

R Goto-Tamura, Y Takesue, S Takesue.   

Abstract

In a number of animal species soluble NADH-cytochrome b5 reductase of erythrocytes was compared with membrane-bound NADH-cytochrome b5 reductase of liver microsomes by using an antibody to purified NADH-cytochrome b5 reductase from rat liver microsomes. The results obtained indicated clearly that they are immunologically very similar to each other. The data with erythrocyte ghosts suggested that cytochrome b5 and NADH-cytochrome b5 reductase are also present in the ghost.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 2319     DOI： 10.1016/0005-2728(76)90186-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


  9 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay.

Authors:  N Borgese; G Pietrini; S Gaetani
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  A transmembranous NADH-dehydrogenase in human erythrocyte membranes.

Authors:  C Grebing; F L Crane; H Löw; K Hall
Journal:  J Bioenerg Biomembr       Date:  1984-12       Impact factor: 2.945

4.  The inhibitory effect of halides and carboxylates on hepatic NADH: cytochrome b5 oxidoreductase.

Authors:  M Tamura; T Yubisui; M Takeshita
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

5.  Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities.

Authors:  Kei Takahashi; Yuki Oda; Yasuyuki Toyoda; Tatsuki Fukami; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Pharm Res       Date:  2014-03       Impact factor: 4.200

6.  Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.

Authors:  D Choury; A Leroux; J C Kaplan
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  Interaction between cytochrome b5 and hemoglobin: involvement of beta 66 (E10) and beta 95 (FG2) lysyl residues of hemoglobin.

Authors:  G Gacon; D Lostanlen; D Labie; J C Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  Assignment of NADH-cytochrome b5 reductase (DIA1 locus) to human chromosome 22.

Authors:  C Junien; M Vibert; D Weil; N Van-Cong; J C Kaplan
Journal:  Hum Genet       Date:  1978-06-27       Impact factor: 4.132

9.  NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Authors:  D Lostanlen; G Lenoir; J C Kaplan
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.